Skip to content

Treatment of stage I seminoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN54221666
Enrollment
478
Registered
2001-02-28
Start date
1989-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Testicular cancer

Interventions

Two arms both receive 30 Gy in 15 fractions radiotherapy. Arm 1: Para-aortic strip field Arm 2: Dog led field

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Stage I disease, histologically confirmed seminomatous germ cell tumour

Exclusion criteria

Exclusion criteria: Patients with previous ipsilateral inguinal operations.

Design outcomes

Primary

MeasureTime frame
Pelvic recurrence rate

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026